HER2 Testing and Reporting in Endometrial Serous Carcinoma: Practical Recommendations for HER2 Immunohistochemistry and Fluorescent In Situ Hybridization: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
Buza N.
Int J Gynecol Pathol. 2021 Jan;40(1):17-23. doi: 10.1097/PGP.0000000000000711.
Endometrial Hyperplasia.
Ring KL, Mills AM, Modesitt SC.
Obstet Gynecol. 2022 Dec 1;140(6):1061-1075. doi: 10.1097/AOG.0000000000004989. Epub 2022 Nov 2.
Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non-invasive vaginal swab.
Weimer J, Hüttmann M, Nusilati A, Andreas S, Röseler J, Tribian N, Rogmans C, Stope MB, Dahl E, Mustea A, Stickeler E, Hedemann N, Flörkemeier I, Tiemann K, Magadeeva S, Dempfle A, Arnold N, Maass N, Bauerschlag D.
J Cell Mol Med. 2023 Feb;27(3):379-391. doi: 10.1111/jcmm.17658. Epub 2023 Jan 10.
Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms.
Clarke MA, Long BJ, Sherman ME, Lemens MA, Podratz KC, Hopkins MR, Ahlberg LJ, Mc Guire LJ, Laughlin-Tommaso SK, Bakkum-Gamez JN, Wentzensen N.
Am J Obstet Gynecol. 2020 Oct;223(4):549.e1-549.e13. doi: 10.1016/j.ajog.2020.03.032. Epub 2020 Apr 5.
Endometrial carcinoma in situ in postmenopausal women.
Spiegel GW.
Am J Surg Pathol. 1995 Apr;19(4):417-32. doi: 10.1097/00000478-199504000-00003.
Characteristics of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Endometrial Serous Carcinoma.
Buza N, Hui P.
Arch Pathol Lab Med. 2022 Jun 10;146(5):0. doi: 10.5858/arpa.2021-0547-OA.
Vimentin Protein In Situ Expression Predicts Less Tumor Metastasis and Overall Better Survival of Endometrial Carcinoma.
Zhang X, Cao G, Diao X, Bai W, Zhang Y, Wang S.
Dis Markers. 2022 Mar 14;2022:5240046. doi: 10.1155/2022/5240046. eCollection 2022.
Clear Cell Endometrial Carcinoma In Situ (CCEIC) Exists!
Islam KMS, Lawrence WD, Quddus MR.
Int J Surg Pathol. 2020 May;28(3):290-291. doi: 10.1177/1066896919868021. Epub 2019 Aug 16.
HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma.
Cagaanan A, Stelter B, Vu N, Rhode EN, Stewart T, Hui P, Buza N, Al-Niaimi A, Flynn C, Weisman PS, McGregor SM.
Int J Gynecol Pathol. 2022 Mar 1;41(2):132-141. doi: 10.1097/PGP.0000000000000783.
Altered glycosylation of glycodelin in endometrial carcinoma.
Hautala LC, Pang PC, Antonopoulos A, Pasanen A, Lee CL, Chiu PCN, Yeung WSB, Loukovaara M, Bützow R, Haslam SM, Dell A, Koistinen H.
Lab Invest. 2020 Jul;100(7):1014-1025. doi: 10.1038/s41374-020-0411-x. Epub 2020 Mar 23.
